| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1005054778 |
| P356 | DOI | 10.1186/S13014-014-0241-3 |
| P932 | PMC publication ID | 4239322 |
| P698 | PubMed publication ID | 25398516 |
| P5875 | ResearchGate publication ID | 268336373 |
| P2093 | author name string | John Lynch | |
| Anatoly Dritschilo | |||
| Sean Collins | |||
| Joy S Kim | |||
| Leonard N Chen | |||
| Simeng Suy | |||
| Siyuan Lei | |||
| Brian Collins | |||
| Einsley Janowski | |||
| P2860 | cites work | A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity | Q29547290 |
| The impact of prostate volume following neoadjuvant androgen deprivation on quality of life and voiding symptoms in patients undergoing permanent prostate brachytherapy | Q30310786 | ||
| Higher-than-conventional radiation doses in localized prostate cancer treatment: a meta-analysis of randomized, controlled trials | Q33484004 | ||
| Stereotactic body radiotherapy for organ-confined prostate cancer | Q33528163 | ||
| Clinical characteristics and management of late urinary symptom flare following stereotactic body radiation therapy for prostate cancer | Q33659901 | ||
| Randomized trial comparing conventional-dose with high-dose conformal radiation therapy in early-stage adenocarcinoma of the prostate: long-term results from proton radiation oncology group/american college of radiology 95-09 | Q33710935 | ||
| Urinary morbidity following ultrasound-guided transperineal prostate seed implantation. | Q33728655 | ||
| The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association | Q33846043 | ||
| Comparative effectiveness of external-beam radiation approaches for prostate cancer | Q34026731 | ||
| Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation | Q34193483 | ||
| Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference | Q34541651 | ||
| Radical prostatectomy, external beam radiotherapy <72 Gy, external beam radiotherapy > or =72 Gy, permanent seed implantation, or combined seeds/external beam radiotherapy for stage T1-T2 prostate cancer. | Q35617249 | ||
| HDR Brachytherapy in the Management of High-Risk Prostate Cancer | Q35810413 | ||
| The radiobiology of prostate cancer including new aspects of fractionated radiotherapy | Q36217139 | ||
| Hypofractionated stereotactic body radiation therapy as monotherapy for intermediate-risk prostate cancer | Q36604355 | ||
| Stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer: the Georgetown University experience | Q36722591 | ||
| Hypofractionation for prostate cancer: a critical review | Q37033108 | ||
| Patient-reported outcomes after 3-dimensional conformal, intensity-modulated, or proton beam radiotherapy for localized prostate cancer | Q37139334 | ||
| Intrafractional motion of the prostate during hypofractionated radiotherapy | Q37301004 | ||
| Androgen deprivation therapy: minimizing exposure and mitigating side effects | Q38041543 | ||
| Factors predicting for postimplantation urinary retention after permanent prostate brachytherapy. | Q39424002 | ||
| Stereotactic body radiotherapy for low-risk prostate cancer: five-year outcomes | Q41775778 | ||
| Stereotactic body radiotherapy for localized prostate cancer: disease control and quality of life at 6 years | Q41895986 | ||
| Preliminary toxicity analysis of 3-dimensional conformal radiation therapy versus intensity modulated radiation therapy on the high-dose arm of the Radiation Therapy Oncology Group 0126 prostate cancer trial | Q41981580 | ||
| Six-Dimensional Correction of Intra-Fractional Prostate Motion with CyberKnife Stereotactic Body Radiation Therapy | Q42175056 | ||
| Health-related quality of life after stereotactic body radiation therapy for localized prostate cancer: results from a multi-institutional consortium of prospective trials | Q44160340 | ||
| Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial | Q44375182 | ||
| Stereotactic hypofractionated accurate radiotherapy of the prostate (SHARP), 33.5 Gy in five fractions for localized disease: first clinical trial results | Q44927559 | ||
| Multi-institutional prospective evaluation of bowel quality of life after prostate external beam radiation therapy identifies patient and treatment factors associated with patient-reported outcomes: the PROSTQA experience. | Q45915022 | ||
| Improved clinical outcomes with high-dose image guided radiotherapy compared with non-IGRT for the treatment of clinically localized prostate cancer. | Q46012448 | ||
| Urinary symptom flare in 712 125I prostate brachytherapy patients: long-term follow-up | Q46158698 | ||
| Variation in Continence and Potency by Definition | Q46178123 | ||
| Long-term outcomes from a prospective trial of stereotactic body radiotherapy for low-risk prostate cancer | Q46224660 | ||
| Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer | Q46656860 | ||
| The influence of prostate volume on outcome after high-dose-rate brachytherapy alone for localized prostate cancer | Q48016821 | ||
| The impact of pretreatment prostate volume on severe acute genitourinary toxicity in prostate cancer patients treated with intensity-modulated radiation therapy. | Q51771917 | ||
| Stereotactic body radiotherapy for localized prostate cancer: interim results of a prospective phase II clinical trial. | Q53209670 | ||
| Image-guided stereotactic body radiation therapy for localized prostate cancer. | Q53228158 | ||
| Urinary symptom flare following I-125 prostate brachytherapy. | Q53300115 | ||
| Stereotactic body radiotherapy for localized prostate cancer: pooled analysis from a multi-institutional consortium of prospective phase II trials. | Q55057405 | ||
| Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. | Q55067996 | ||
| Long-Term Results of the M. D. Anderson Randomized Dose-Escalation Trial for Prostate Cancer | Q59650976 | ||
| Incidence of Late Rectal and Urinary Toxicities After Three-Dimensional Conformal Radiotherapy and Intensity-Modulated Radiotherapy for Localized Prostate Cancer | Q62514147 | ||
| Clinical experience with intensity modulated radiation therapy (IMRT) in prostate cancer | Q62514253 | ||
| Use of TRUS to predict pubic arch interference of prostate brachytherapy | Q74607969 | ||
| Long-term urinary function after transperineal brachytherapy for patients with large prostate glands | Q77308117 | ||
| Risk factors for acute urinary retention requiring temporary intermittent catheterization after prostate brachytherapy: a prospective study | Q77648063 | ||
| Quality of life and satisfaction with outcome among prostate-cancer survivors | Q80917895 | ||
| Toxicity profile with a large prostate volume after external beam radiotherapy for localized prostate cancer | Q81249488 | ||
| The influence of isotope and prostate volume on urinary morbidity after prostate brachytherapy | Q81295616 | ||
| Long-term urinary sequelae following 125iodine prostate brachytherapy | Q81588069 | ||
| Hypofractionated stereotactic body radiotherapy in low-risk prostate adenocarcinoma: preliminary results of a multi-institutional phase 1 feasibility trial | Q82966826 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | adaptive radiation therapy | Q180507 |
| P304 | page(s) | 241 | |
| P577 | publication date | 2014-11-15 | |
| P1433 | published in | Radiation Oncology | Q2313370 |
| P1476 | title | Stereotactic body radiation therapy (SBRT) for prostate cancer in men with large prostates (≥50 cm(3)). | |
| P478 | volume | 9 |
| Q26738278 | A comparison of robotic arm versus gantry linear accelerator stereotactic body radiation therapy for prostate cancer |
| Q59807871 | A new plan quality objective function for determining optimal collimator combinations in prostate cancer treatment with stereotactic body radiation therapy using CyberKnife |
| Q41866253 | CyberKnife-based prostate cancer patient radioablation - early results of irradiation in 200 patients |
| Q40982235 | Cyberknife Radioablation of Prostate Cancer – Preliminary Results for 400 Patients |
| Q48238146 | Moderate hypofractionation for prostate cancer: A user's guide. |
| Q42702939 | Stereotactic radiotherapy for prostate cancer: A review and future directions |
| Q57493403 | The role and importance of SBRT in prostate cancer |
Search more.